157 related articles for article (PubMed ID: 8122886)
1. A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina).
Tsujino S; Tonin P; Shanske S; Nohria V; Boustany RM; Lewis D; Chen YT; DiMauro S
Ann Neurol; 1994 Mar; 35(3):349-53. PubMed ID: 8122886
[TBL] [Abstract][Full Text] [Related]
2. A splice junction mutation in the alpha(M) gene of phosphorylase kinase in a patient with myopathy.
Bruno C; Manfredi G; Andreu AL; Shanske S; Krishna S; Ilse WK; DiMauro S
Biochem Biophys Res Commun; 1998 Aug; 249(3):648-51. PubMed ID: 9731190
[TBL] [Abstract][Full Text] [Related]
3. Retarded and aberrant splicings caused by single exon mutation in a phosphoglycerate kinase variant.
Ookawara T; Davé V; Willems P; Martin JJ; de Barsy T; Matthys E; Yoshida A
Arch Biochem Biophys; 1996 Mar; 327(1):35-40. PubMed ID: 8615693
[TBL] [Abstract][Full Text] [Related]
4. Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations.
Spiegel R; Gomez EA; Akman HO; Krishna S; Horovitz Y; DiMauro S
Neuromuscul Disord; 2009 Mar; 19(3):207-11. PubMed ID: 19157875
[TBL] [Abstract][Full Text] [Related]
5. Intronic mutation in the PGK1 gene may cause recurrent myoglobinuria by aberrant splicing.
Shirakawa K; Takahashi Y; Miyajima H
Neurology; 2006 Mar; 66(6):925-7. PubMed ID: 16567715
[TBL] [Abstract][Full Text] [Related]
6. Phosphoglycerate kinase deficiency myopathy: biochemical and immunological studies of the mutant enzyme.
Bresolin N; Miranda A; Chang HW; Shanske S; DiMauro S
Muscle Nerve; 1984 Sep; 7(7):542-51. PubMed ID: 6544372
[TBL] [Abstract][Full Text] [Related]
7. Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation.
Hamano T; Mutoh T; Sugie H; Koga H; Kuriyama M
Neurology; 2000 Mar; 54(5):1188-90. PubMed ID: 10720297
[TBL] [Abstract][Full Text] [Related]
8. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
[TBL] [Abstract][Full Text] [Related]
9. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.
Yagi M; Takeshima Y; Wada H; Nakamura H; Matsuo M
Hum Genet; 2003 Feb; 112(2):164-70. PubMed ID: 12522557
[TBL] [Abstract][Full Text] [Related]
10. A phosphoglycerate kinase mutant (PGK Herlev; D285V) in a Danish patient with isolated chronic hemolytic anemia: mechanism of mutation and structure-function relationships.
Valentin C; Birgens H; Craescu CT; Brødum-Nielsen K; Cohen-Solal M
Hum Mutat; 1998; 12(4):280-7. PubMed ID: 9744480
[TBL] [Abstract][Full Text] [Related]
11. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
12. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
Baskin B; Banwell B; Khater RA; Hawkins C; Ray PN
Neuromuscul Disord; 2009 Mar; 19(3):189-92. PubMed ID: 19230662
[TBL] [Abstract][Full Text] [Related]
13. Phosphoglycerate kinase deficiency: biochemical and molecular genetic studies in a new myopathic variant (PGK Alberta).
Tonin P; Shanske S; Miranda AF; Brownell AK; Wyse JP; Tsujino S; DiMauro S
Neurology; 1993 Feb; 43(2):387-91. PubMed ID: 7679780
[TBL] [Abstract][Full Text] [Related]
14. A novel single-base substitution (380C>T) that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene.
Nakamura K; Fukao T; Perez-Cerda C; Luque C; Song XQ; Naiki Y; Kohno Y; Ugarte M; Kondo N
Mol Genet Metab; 2001 Feb; 72(2):115-21. PubMed ID: 11161837
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of Stickler syndrome: a COL2A1 stop codon mutation screening strategy that is not compromised by mutant mRNA instability.
Freddi S; Savarirayan R; Bateman JF
Am J Med Genet; 2000 Feb; 90(5):398-406. PubMed ID: 10706362
[TBL] [Abstract][Full Text] [Related]
16. Molecular abnormality of a phosphoglycerate kinase variant (PGK-Alabama).
Yoshida A; Twele TW; Davé V; Beutler E
Blood Cells Mol Dis; 1995; 21(3):179-81. PubMed ID: 8673469
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
[TBL] [Abstract][Full Text] [Related]
18. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.
Gallinaro L; Sartorello F; Pontara E; Cattini MG; Bertomoro A; Bartoloni L; Pagnan A; Casonato A
Thromb Haemost; 2006 Dec; 96(6):711-6. PubMed ID: 17139363
[TBL] [Abstract][Full Text] [Related]
19. A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization.
Fermo E; Bianchi P; Chiarelli LR; Maggi M; Mandarà GM; Vercellati C; Marcello AP; Barcellini W; Cortelezzi A; Valentini G; Zanella A
Mol Genet Metab; 2012 Aug; 106(4):455-61. PubMed ID: 22705348
[TBL] [Abstract][Full Text] [Related]
20. Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene.
Hoshiya M; Christian BP; Cromie WJ; Kim H; Zhan Y; MacLaughlin DT; Donahoe PK
Birth Defects Res A Clin Mol Teratol; 2003 Oct; 67(10):868-74. PubMed ID: 14745940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
